|Study Description:||The goal of this clinical research study is to find the highest tolerable dose |
of study drug WT2725 that can be given to patients with the following cancers:
acute myeloid leukemia, ovarian cancer, gilioblastoma, or non-small cell lung
cancer. The safety of WT2725 will also be studied.
WT2725 is a vaccine designed to help your immune system to fight against the
cancer cells by targeting a protein found in cancer cells called WT1, although
it is not known if it will do this. It is hoped that this may slow down the
growth of or kill cancer cells. This is the first study using WT2725 in